Medicine and Dentistry
Bleeding Disorder
100%
Menorrhagia
82%
Platelet
69%
Thrombosis
67%
Bleeding
58%
Venous Thromboembolism
46%
Blood Stasis
40%
Haemophilia
36%
Adolescent
32%
Pediatrics
32%
Thrombocyte Aggregation
30%
Thrombocyte Activation
29%
Anticoagulation
28%
Hemostat
26%
Thrombocyte Function
25%
Levonorgestrel
25%
Pediatric Trauma
25%
P21 Activated Kinase
25%
Idiopathic Thrombocytopenic Purpura
25%
Adolescence
25%
Mediator
18%
Von Willebrand Disease
17%
Thrombocyte Adhesion
16%
Decision Making
16%
Rho Guanine Nucleotide Binding Protein
16%
Kinase Signaling
15%
Diagnosis
15%
Neonate
15%
Quality of Life
15%
Haemophilia B
15%
Symptom
15%
Glycoprotein
14%
Platelet Disorder
14%
Filopodia
14%
Thromboembolism
14%
Pharmacokinetics
13%
Ciclonicate
12%
Treatment Duration
12%
Arm
12%
Circulating Tumor Cell
12%
Drug Dose Regimen
12%
Factor IX
12%
Randomized Controlled Trial
12%
Hormone Therapy
12%
Echography
12%
Medical Decision Making
12%
Thrombin
12%
Cross Sectional Study
12%
Congenital Hemolytic Anemia
12%
Attitude
12%
Keyphrases
Bleeding Disorders
44%
Bleeding
39%
Abnormal Uterine Bleeding
39%
Venous Thromboembolism
31%
Pediatric Trauma
25%
Immune Thrombocytopenia
25%
Thrombosis
25%
Pediatric Thrombosis
25%
Second-line Treatment
25%
Abnormal Bleeding
25%
Prediction Algorithms
15%
Central Venous Catheter
13%
Venous Thromboembolic
12%
Medical Insurance Claim
12%
Intrauterine System
12%
Prospective Cohort Study
12%
Provider Attitudes
12%
Pediatric Population
12%
Patient-centered Outcomes
12%
Pediatric Patients
12%
Provider Practices
12%
Platelet Aggregation
12%
Kinase Signaling
12%
Congenital Bleeding Disorders
12%
Neonatal Platelets
12%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
12%
Risk Stratification
12%
Aggregate Stability
12%
Glycoprotein Receptors
12%
Formation Stability
12%
Filopodia Formation
12%
Chronic Disease Management
12%
Physician Decision-making
12%
Thromboprophylaxis
12%
PAK1
12%
Platelet Count
12%
Anticoagulation
12%
Hemostasis
12%
Oral Hormonal Therapy
12%
Thrombosis in children
12%
Young Women
12%
Acquired Bleeding Disorders
12%
Inherited Bleeding Disorders
12%
Romiplostim
11%
Eltrombopag
11%
Injured children
10%
Moderate Risk
10%
Von Willebrand Factor Assays
9%
Iron Deficiency
8%
Health-related Quality of Life
8%